P
PTC THERAPEUTICS INC
NASDAQ: PTCT (PTC Therapeutics, Inc.)
Last update: yesterday, 9:34PM72.48
-3.16 (-4.18%)
| Previous Close | 75.64 |
| Open | 76.73 |
| Volume | 877,868 |
| Avg. Volume (3M) | 1,573,593 |
| Market Cap | 5,819,296,768 |
| Price / Earnings (TTM) | 8.43 |
| Price / Sales | 3.59 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Profit Margin | 33.56% |
| Operating Margin (TTM) | 82.43% |
| Diluted EPS (TTM) | 6.39 |
| Quarterly Revenue Growth (YOY) | 459.70% |
| Current Ratio (MRQ) | 3.89 |
| Operating Cash Flow (TTM) | 691.65 M |
| Levered Free Cash Flow (TTM) | 526.00 M |
| Return on Assets (TTM) | 24.42% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | PTC Therapeutics, Inc. | Bullish | Bullish |
AIStockmoo Score
-0.3
| Analyst Consensus | 1.5 |
| Insider Activity | -3.5 |
| Price Volatility | -1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.30 |
|
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 2.40% |
| % Held by Institutions | 101.06% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Jefferies Financial Group Inc. | 30 Sep 2025 | 1,584,678 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 93.00 (Wells Fargo, 28.31%) | Buy |
| Median | 75.00 (3.48%) | |
| Low | 50.00 (Goldman Sachs, -31.02%) | Sell |
| Average | 73.86 (1.90%) | |
| Total | 2 Buy, 4 Hold, 1 Sell | |
| Avg. Price @ Call | 72.34 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| RBC Capital | 01 Dec 2025 | 91.00 (25.55%) | Hold | 79.20 |
| 05 Nov 2025 | 82.00 (13.13%) | Buy | 71.77 | |
| Barclays | 06 Nov 2025 | 68.00 (-6.18%) | Hold | 72.59 |
| Citigroup | 05 Nov 2025 | 75.00 (3.48%) | Hold | 71.77 |
| Goldman Sachs | 05 Nov 2025 | 50.00 (-31.02%) | Sell | 71.77 |
| TD Cowen | 05 Nov 2025 | 63.00 (-13.08%) | Hold | 71.77 |
| Wells Fargo | 05 Nov 2025 | 93.00 (28.31%) | Buy | 71.77 |
| Jefferies | 28 Oct 2025 | 77.00 (6.24%) | Buy | 67.49 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ALMSTEAD NEIL GREGORY | - | 76.93 | -3,351 | -257,745 |
| BOULDING MARK ELLIOTT | - | 77.02 | -15,231 | -1,173,514 |
| GOLDEN LEE SCOTT | - | 76.93 | -2,848 | -218,918 |
| GRAVIER PIERRE | - | 76.70 | -2,139 | -164,061 |
| KLEIN MATTHEW B. | - | 76.93 | -10,679 | -821,085 |
| PAUWELS ERIC | - | 77.13 | -10,489 | -808,267 |
| REEVE EMMA | - | 76.76 | -734 | -56,342 |
| UTTER CHRISTINE MARIE | - | 76.93 | -3,650 | -280,777 |
| Aggregate Net Quantity | -49,121 | |||
| Aggregate Net Value ($) | -3,780,709 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 76.98 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| PAUWELS ERIC | Officer | 12 Jan 2026 | Automatic sell (-) | 1,024 | 77.59 | 79,452 |
| BOULDING MARK ELLIOTT | Officer | 09 Jan 2026 | Automatic sell (-) | 2,314 | 77.53 | 179,404 |
| PAUWELS ERIC | Officer | 09 Jan 2026 | Automatic sell (-) | 1,722 | 77.53 | 133,507 |
| BOULDING MARK ELLIOTT | Officer | 08 Jan 2026 | Automatic sell (-) | 2,747 | 76.85 | 211,107 |
| BOULDING MARK ELLIOTT | Officer | 08 Jan 2026 | Sell (-) | 1,286 | 76.85 | 98,829 |
| PAUWELS ERIC | Officer | 08 Jan 2026 | Automatic sell (-) | 3,148 | 76.85 | 241,924 |
| PAUWELS ERIC | Officer | 08 Jan 2026 | Sell (-) | 1,454 | 76.85 | 111,740 |
| GOLDEN LEE SCOTT | Officer | 08 Jan 2026 | Sell (-) | 866 | 76.85 | 66,552 |
| ALMSTEAD NEIL GREGORY | Officer | 08 Jan 2026 | Sell (-) | 881 | 76.85 | 67,705 |
| ALMSTEAD NEIL GREGORY | Officer | 08 Jan 2026 | Sell (-) | 59 | 76.85 | 4,534 |
| KLEIN MATTHEW B. | Officer | 08 Jan 2026 | Sell (-) | 2,514 | 76.85 | 193,201 |
| UTTER CHRISTINE MARIE | Officer | 08 Jan 2026 | Sell (-) | 1,034 | 76.85 | 79,463 |
| ALMSTEAD NEIL GREGORY | Officer | 07 Jan 2026 | Sell (-) | 1,026 | 77.24 | 79,248 |
| ALMSTEAD NEIL GREGORY | Officer | 07 Jan 2026 | Sell (-) | 52 | 77.24 | 4,016 |
| BOULDING MARK ELLIOTT | Officer | 07 Jan 2026 | Sell (-) | 1,503 | 77.24 | 116,092 |
| BOULDING MARK ELLIOTT | Officer | 07 Jan 2026 | Automatic sell (-) | 3,376 | 77.24 | 260,762 |
| BOULDING MARK ELLIOTT | Officer | 07 Jan 2026 | Option execute | 3,376 | - | - |
| KLEIN MATTHEW B. | Officer | 07 Jan 2026 | Sell (-) | 3,016 | 77.24 | 232,956 |
| PAUWELS ERIC | Officer | 07 Jan 2026 | Sell (-) | 1,352 | 77.24 | 104,428 |
| GOLDEN LEE SCOTT | Officer | 07 Jan 2026 | Sell (-) | 642 | 77.24 | 49,588 |
| UTTER CHRISTINE MARIE | Officer | 07 Jan 2026 | Sell (-) | 1,235 | 77.24 | 95,391 |
| ALMSTEAD NEIL GREGORY | Officer | 06 Jan 2026 | Sell (-) | 1,279 | 76.70 | 98,099 |
| ALMSTEAD NEIL GREGORY | Officer | 06 Jan 2026 | Sell (-) | 54 | 76.70 | 4,142 |
| BOULDING MARK ELLIOTT | Officer | 06 Jan 2026 | Sell (-) | 1,739 | 76.70 | 133,381 |
| KLEIN MATTHEW B. | Officer | 06 Jan 2026 | Sell (-) | 5,149 | 76.70 | 394,928 |
| PAUWELS ERIC | Officer | 06 Jan 2026 | Sell (-) | 1,789 | 76.70 | 137,216 |
| GOLDEN LEE SCOTT | Officer | 06 Jan 2026 | Sell (-) | 1,340 | 76.70 | 102,778 |
| GRAVIER PIERRE | Officer | 06 Jan 2026 | Sell (-) | 2,139 | 76.70 | 164,061 |
| UTTER CHRISTINE MARIE | Officer | 06 Jan 2026 | Sell (-) | 1,381 | 76.70 | 105,923 |
| REEVE EMMA | Director | 05 Jan 2026 | Automatic sell (-) | 734 | 76.76 | 56,342 |
| REEVE EMMA | Director | 05 Jan 2026 | Option execute | 734 | - | - |
| BOULDING MARK ELLIOTT | Officer | 05 Jan 2026 | Automatic sell (-) | 2,266 | 76.76 | 173,938 |
| BOULDING MARK ELLIOTT | Officer | 05 Jan 2026 | Option execute | 2,266 | - | - |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |